Trials / Completed
CompletedNCT00086710
Study of Enfuvirtide in HIV-Positive Subjects
An Open-label, Randomized, Cross-over Study in HIV-Positive Subjects to Determine and Compare the Single-dose Pharmacokinetics of Enfuvirtide after a Single 90 mg SC Administration
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 26 (planned)
- Sponsor
- Trimeris · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
A total of 26 patients will be admitted to the clinic where they will be dosed with each injection device. There will be a 7-day washout between doses and a 7-10 day follow-up period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fuzeon |
Timeline
- First posted
- 2004-07-13
- Last updated
- 2005-06-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00086710. Inclusion in this directory is not an endorsement.